6-142753563-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_006734.4(HIVEP2):āc.6885A>Gā(p.Pro2295=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.661 in 1,613,816 control chromosomes in the GnomAD database, including 355,760 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.71 ( 38756 hom., cov: 32)
Exomes š: 0.66 ( 317004 hom. )
Consequence
HIVEP2
NM_006734.4 synonymous
NM_006734.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.141
Genes affected
HIVEP2 (HGNC:4921): (HIVEP zinc finger 2) This gene encodes a member of a family of closely related, large, zinc finger-containing transcription factors. The encoded protein regulates transcription by binding to regulatory regions of various cellular and viral genes that maybe involved in growth, development and metastasis. The protein contains the ZAS domain comprised of two widely separated regions of zinc finger motifs, a stretch of highly acidic amino acids and a serine/threonine-rich sequence. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-142753563-T-C is Benign according to our data. Variant chr6-142753563-T-C is described in ClinVar as [Benign]. Clinvar id is 402939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-142753563-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.141 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.831 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HIVEP2 | NM_006734.4 | c.6885A>G | p.Pro2295= | synonymous_variant | 10/10 | ENST00000367603.8 | NP_006725.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HIVEP2 | ENST00000367603.8 | c.6885A>G | p.Pro2295= | synonymous_variant | 10/10 | 1 | NM_006734.4 | ENSP00000356575 | P1 | |
ENST00000437067.1 | n.153T>C | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.708 AC: 107554AN: 151974Hom.: 38716 Cov.: 32
GnomAD3 genomes
AF:
AC:
107554
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.686 AC: 170775AN: 249086Hom.: 59272 AF XY: 0.684 AC XY: 92442AN XY: 135158
GnomAD3 exomes
AF:
AC:
170775
AN:
249086
Hom.:
AF XY:
AC XY:
92442
AN XY:
135158
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.656 AC: 959160AN: 1461724Hom.: 317004 Cov.: 57 AF XY: 0.659 AC XY: 478866AN XY: 727178
GnomAD4 exome
AF:
AC:
959160
AN:
1461724
Hom.:
Cov.:
57
AF XY:
AC XY:
478866
AN XY:
727178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.708 AC: 107647AN: 152092Hom.: 38756 Cov.: 32 AF XY: 0.708 AC XY: 52630AN XY: 74332
GnomAD4 genome
AF:
AC:
107647
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
52630
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2688
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 17, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Intellectual disability, autosomal dominant 43 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at